Aseptika in St Ives and Zenzium in Cheshire have been awarded an unspecified grant from the UK's innovation agency to leverage AI and develop a new home-based early warning system for people with severe respiratory disease. Artificial Intelligence will automatically analyse and learn from data generated by the patient at home, using easy-to-use medical monitors and wearables, which connect to Aseptika's Activ8rlives App. The companies will introduce a Smart LungHealth system in the form of the Cloud-connecting Activ8rlives4 App and will also embed the AI alerting system into Aseptika's future wearable medical monitor called the BuddyWOTCH, currently in development. Aseptika and Zenzium will collaborate to create a system to automatically warn when patients health is declining. Looking at anonymised information gathered from previous clinical trials showed that many patients do not treat exacerbations and may not even be aware that they are having them.